BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17994190)

  • 21. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism.
    Qian Q; Wang Y; Zhou R; Li J; Wang B; Glatt S; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):103-9. PubMed ID: 12627475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD).
    Turic D; Williams H; Langley K; Owen M; Thapar A; O'Donovan MC
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):64-7. PubMed ID: 15635644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
    J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal risk factors interacting with catechol O-methyltransferase and the serotonin transporter gene predict ASD symptoms in children with ADHD.
    Nijmeijer JS; Hartman CA; Rommelse NN; Altink ME; Buschgens CJ; Fliers EA; Franke B; Minderaa RB; Ormel J; Sergeant JA; Verhulst FC; Buitelaar JK; Hoekstra PJ
    J Child Psychol Psychiatry; 2010 Nov; 51(11):1242-50. PubMed ID: 20868372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions Between Early Trauma and Catechol-O-Methyltransferase Genes on Inhibitory Deficits in Children With ADHD.
    Park S; Kim BN; Kim JW; Shin MS; Yoo HJ; Cho SC
    J Atten Disord; 2017 Feb; 21(3):183-189. PubMed ID: 25063767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association between attention-deficit hyperactivity disorder and catechol-O-methyltransferase gene in Chinese.
    Jiang SD; Wu XD; Zhang Y; Tang GM; Qian YP; Wang DX
    Yi Chuan Xue Bao; 2005 Aug; 32(8):784-8. PubMed ID: 16231731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD.
    Hawi Z; Matthews N; Barry E; Kirley A; Wagner J; Wallace RH; Heussler HS; Vance A; Gill M; Bellgrove MA
    Psychopharmacology (Berl); 2013 Feb; 225(4):895-902. PubMed ID: 23052569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.
    Thakur GA; Sengupta SM; Grizenko N; Choudhry Z; Joober R
    PLoS One; 2012; 7(11):e49616. PubMed ID: 23185385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN; Ruan LM; Le YP; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls.
    van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA
    Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.
    Xu Z; Zhang Z; Shi Y; Pu M; Yuan Y; Zhang X; Li L
    J Affect Disord; 2011 Sep; 133(1-2):165-73. PubMed ID: 21680027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD.
    Taerk E; Grizenko N; Ben Amor L; Lageix P; Mbekou V; Deguzman R; Torkaman-Zehi A; Ter Stepanian M; Baron C; Joober R
    BMC Med Genet; 2004 Dec; 5():30. PubMed ID: 15613245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children.
    Tahir E; Curran S; Yazgan Y; Ozbay F; Cirakoglu B; Asherson PJ
    Am J Med Genet; 2000 Jun; 96(3):285-8. PubMed ID: 10898901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of COMT in ADHD: a systematic meta-analysis.
    Sun H; Yuan F; Shen X; Xiong G; Wu J
    Mol Neurobiol; 2014 Feb; 49(1):251-61. PubMed ID: 23907791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Akutagava-Martins GC; Salatino-Oliveira A; Kieling C; Genro JP; Polanczyk GV; Anselmi L; Menezes AM; Gonçalves H; Wehrmeister FC; Barros FC; Callegari-Jacques SM; Rohde LA; Hutz MH
    J Psychiatry Neurosci; 2016 Oct; 41(6):405-412. PubMed ID: 27327562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of genetic variants in the BDNF, COMT, DAT1 and SERT genes in Colombian children with attention deficit disorder].
    Ortega-Rojas J; Arboleda-Bustos CE; Morales L; Benítez BA; Beltrán D; Izquierdo Á; Arboleda H; Vásquez R
    Rev Colomb Psiquiatr; 2017; 46(4):222-228. PubMed ID: 29122229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample.
    Hawi Z; Millar N; Daly G; Fitzgerald M; Gill M
    Am J Med Genet; 2000 Jun; 96(3):282-4. PubMed ID: 10898900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.